Alprazolam 2 mg tablets recalled due to potential cross-contamination
Direct Rx is recalling Alprazolam C-IV 2 mg tablets (Lot #07NO1901, expiration 5/31/22) distributed in Florida, Georgia, and Louisiana due to potential cross-contamination identified at the contract manufacturer Ultra Tab Laboratories Inc.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this recall as Class II. The source text does not report any actual illnesses, injuries, or confirmed cross-contamination—only the potential for it due to CGMP deviations. This meets the rubric criterion for a Moderate severity recall: manufacturing/precautionary issue without reported adverse outcomes.
Plain-English summary
Direct Rx is recalling Alprazolam C-IV 2 mg tablets in 60-count bottles (NDC 72189-0058-60, Lot #07NO1901, expiration date 5/31/22). Eight bottles were distributed to Florida, Georgia, and Louisiana.
The recall was initiated due to potential cross-contamination at Ultra Tab Laboratories Inc., the contract manufacturer. The contamination constitutes a deviation from Current Good Manufacturing Practice (CGMP) standards.
Patients currently taking this medication should contact their healthcare provider or pharmacist for guidance. Consumers in possession of the recalled product should not use it and should return it to their pharmacy or consult their healthcare provider for replacement medication.
The recalled product
- Product
- Alprazolam C-IV 2 mg, 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut Ridge, NY 10977 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0058-60
- Manufacturer
- Direct Rx
- Affected units
- 8
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 07NO1901 Exp. 5/31/22
Distribution
Part of a larger recall action
This product is one of 2 recalled by Direct Rx under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Direct Rx
See all →- ModerateDuloxetine 30 mg capsules recalled for impurity above FDA limits
FDA (Drugs) · 2026-07-01
- HighDuloxetine delayed-release capsules exceed the interim nitrosamine impurity limit
FDA (Drugs) · 2025-08-13
- HighDirect Rx duloxetine 30 mg capsules exceed the interim nitrosamine limit
FDA (Drugs) · 2025-08-13
- ModerateCiprofloxacin Ophthalmic Solution Recalled for Defective Container Cap
FDA (Drugs) · 2025-04-23
- HighGeneric Ibuprofen 800mg Recalled Due to Failed Impurity and Degradation Specifications
FDA (Drugs) · 2024-11-13
Same hazard · cross contamination
See all →- ModerateSage Products Recalls Chlorhexidine Gluconate Cloth Due to Cross Contamination
FDA (Drugs) · 2026-09-09
- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
- ModeratePrimidone tablets recalled over potential acemetacin cross-contamination at API manufacturer
FDA (Drugs) · 2026-06-17
- HighFly By Jing creamy sesame noodles may contain undeclared peanut
FDA (Food) · 2026-06-03
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27